Open Access

Distribution of estimated 10-year risk of recurrent vascular events and residual risk in a secondary prevention population.

Congress Presentation

About the speaker

Professor Frank Lj Visseren

University Medical Center Utrecht, Utrecht (Netherlands (The))
11 presentations
5 followers

3 more presentations in this session

Individual decision for length of dual antiplatelet therapy after ACS.

Speaker: Professor P. Clemmensen (Hamburg, DE)

Thumbnail

New antidiabetic agents reduce cardiovascular events.

Speaker: Associate Professor J. Schmid (Gais, CH)

Thumbnail

PCSK9-Inhibitions: for whom, when, and how effective.

Speaker: Professor C. Saely (Feldkirch, AT)

Thumbnail

Access the full session

Secondary Prevention: unmet medical needs - Session I

Speakers: Professor F. Visseren, Professor P. Clemmensen, Associate Professor J. Schmid, Professor C. Saely
Thumbnail

About the event

Image

EuroPrevent 2017

6 April - 8 April 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb